The Evolution of Patient Centricity in Pharma (Pre-2020 to 2025): From Aspiration to Embedded Reality
Patient centricity: A defining imperative in healthcare As patient expectations evolve and regulatory bodies demand greater transparency, the pharmaceutical industry is undergoing a profound transformation in terms of patient centricity. Our latest white paper, “The Evolution of Patient Centricity in Pharma (Pre-2020 to 2025): From Aspiration to Embedded Reality,” explores how patient centricity has shifted from…...
Read MoreTop Stories
The Nelson Memo: Igniting a Global Open Data
The landscape of scientific research is undergoing a seismic...
Rare Diseases – An Evolving Medical
A disease is considered rare when it affects fewer than 1 in...
The Paradigm Shift from Traditional Scientific
In the rapidly evolving biopharma landscape, the approach to...
Filter
The Evolution of Patient Centricity in Pharma (Pre-2020 to 2025): From Aspiration to Embedded Reality
Patient centricity: A defining imperative in healthcare As patient expectations evolve and regulatory bodies demand...
MAPS 2025 Decoded: The Medical Affairs Playbook for Successful Drug Launches
At the MAPS Americas 2025 conference in New Orleans, one of the pivotal discussions centered...
Biopharma Trends 2025: 3 Things to Know Right Now
The global business climate is ever-evolving, and 2025 looks like it may be particularly challenging...
Rare Diseases – An Evolving Medical Communications Landscape
A disease is considered rare when it affects fewer than 1 in 2,000 people. However...
It’s Never Too Soon: How and When to Engage Medical Affairs
Engagement with Medical Affairs is critical at every juncture in the drug development process, with...
Leveraging Social Media to Transform Medical Affairs
This whitepaper explores the role of social media in enhancing Medical Affairs functions. As digital...